bicalutamide and Cells, Neoplasm Circulating

bicalutamide has been researched along with Cells, Neoplasm Circulating in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Agarwal, N; Alva, A; Cheng, HH; Chi, KN; Gupta, S; Heath, EI; Higano, CS; Hussain, M; Inoue, Y; Lam, ET; Li, H; Lilly, MB; Pal, SK; Plymate, SR; Quinn, DI; Tangen, CM; Thompson, IM; Vogelzang, NJ; Yu, EY	1
Kempkensteffen, C; Kleinschmidt, K; Köllermann, J; Pantel, K; Rau, T; Schostak, M; Weikert, S	1
Agus, DB; Gross, ME; Jiang, Y; Palma, JF; Wang, Y	1

Trials

1 trial(s) available for bicalutamide and Cells, Neoplasm Circulating

Article	Year
SWOG S0925: A Randomized Phase II Study of Androgen Deprivation Combined With Cixutumumab Versus Androgen Deprivation Alone in Patients With New Metastatic Hormone-Sensitive Prostate Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015, May-10, Volume: 33, Issue:14 Topics: Aged; Androgen Antagonists; Anilides; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Drug Administration Schedule; Gonadotropin-Releasing Hormone; Humans; Logistic Models; Male; Middle Aged; Neoplasm Staging; Neoplastic Cells, Circulating; Nitriles; Prostate-Specific Antigen; Prostatic Neoplasms; Receptor, IGF Type 1; Tosyl Compounds; Treatment Outcome	2015

Article

Year

SWOG S0925: A Randomized Phase II Study of Androgen Deprivation Combined With Cixutumumab Versus Androgen Deprivation Alone in Patients With New Metastatic Hormone-Sensitive Prostate Cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015, May-10, Volume: 33, Issue:14

Topics: Aged; Androgen Antagonists; Anilides; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Drug Administration Schedule; Gonadotropin-Releasing Hormone; Humans; Logistic Models; Male; Middle Aged; Neoplasm Staging; Neoplastic Cells, Circulating; Nitriles; Prostate-Specific Antigen; Prostatic Neoplasms; Receptor, IGF Type 1; Tosyl Compounds; Treatment Outcome

2015

Other Studies

2 other study(ies) available for bicalutamide and Cells, Neoplasm Circulating

Article	Year
Prognostic significance of disseminated tumor cells in the bone marrow of prostate cancer patients treated with neoadjuvant hormone treatment. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Oct-20, Volume: 26, Issue:30 Topics: Aged; Anilides; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Marrow Neoplasms; Chemotherapy, Adjuvant; Disease-Free Survival; Flutamide; Follow-Up Studies; Goserelin; Humans; Leuprolide; Male; Multivariate Analysis; Neoadjuvant Therapy; Neoplastic Cells, Circulating; Nitriles; Prognosis; Prostatectomy; Prostatic Neoplasms; Tosyl Compounds	2008
Detection of androgen receptor mutations in circulating tumor cells in castration-resistant prostate cancer. Clinical chemistry, 2010, Volume: 56, Issue:9 Topics: Androgen Antagonists; Anilides; Antineoplastic Agents; Castration; Docetaxel; Humans; Male; Mutation; Neoplastic Cells, Circulating; Nitriles; Prostatic Neoplasms; Receptors, Androgen; Taxoids; Tosyl Compounds	2010

Article

Year

Prognostic significance of disseminated tumor cells in the bone marrow of prostate cancer patients treated with neoadjuvant hormone treatment.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Oct-20, Volume: 26, Issue:30

Topics: Aged; Anilides; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Marrow Neoplasms; Chemotherapy, Adjuvant; Disease-Free Survival; Flutamide; Follow-Up Studies; Goserelin; Humans; Leuprolide; Male; Multivariate Analysis; Neoadjuvant Therapy; Neoplastic Cells, Circulating; Nitriles; Prognosis; Prostatectomy; Prostatic Neoplasms; Tosyl Compounds

2008

Detection of androgen receptor mutations in circulating tumor cells in castration-resistant prostate cancer.

Clinical chemistry, 2010, Volume: 56, Issue:9

Topics: Androgen Antagonists; Anilides; Antineoplastic Agents; Castration; Docetaxel; Humans; Male; Mutation; Neoplastic Cells, Circulating; Nitriles; Prostatic Neoplasms; Receptors, Androgen; Taxoids; Tosyl Compounds

2010